Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
uzedy
- Development stage
- Approved
- Lead developer
- Teva Pharmaceutical Industries
- Modality
- Small Molecules, Drug Delivery Systems
- Administration
- Subcutaneous
01
Overview
UZEDY is a long-acting, extended-release injectable formulation of risperidone indicated for the treatment of schizophrenia in adults. It is administered subcutaneously (under the skin) and utilizes proprietary SteadyTeq (BEPO) copolymer technology to provide sustained release of risperidone over one or two months per injection. UZEDY is the first subcutaneous, long-acting formulation of risperidone available in both one- and two-month dosing intervals. The mechanism of action involves antagonism at dopamine D2 receptors and serotonin 5-HT2A receptors, which helps balance neurotransmitters implicated in psychosis and mood regulation. UZEDY was developed by MedinCell using their BEPO technology and is distributed by Teva Pharmaceuticals[1][3][4][5][7][8][10].
- Brand names
- Uzedy
- Other names
- risperidone extended-release injectable suspensionTV-46000TV46000TV 46000
02
Targets
DRD2 (Dopamine D2 Receptor)HTR2A (Serotonin receptor 5-HT2A)
Beyond the preview
Go deeper on uzedy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on uzedy.